Merck Covid Vaccine

Generic drug manufacturers will make a more affordable version of Merck's anti-Covid pill for 105 of the world's poorer nations, a UN-backed organisation said on Thursday.

The centre cleared two more vaccines today and one anti-viral drug to boost the fight against the COVID-19 pandemic. The two latest vaccines cleared by India are Corbevax and Covovax. The anti-viral drug Molnupiravir can be used during emergency.

A World Health Organization-led programme to ensure poorer countries get fair access to COVID-19 vaccines, tests and treatments aim to secure antiviral drugs for patients with mild symptoms for as little as $10 per course.

India's Everest Organics Ltd said on Tuesday it had started making the active pharmaceutical ingredient (API) for a generic version of Merck & Co's experimental antiviral drug molnupiravir to treat mild to moderate COVID-19.

Australia will buy 300,000 courses of Merck & Co's experimental antiviral pill, Prime Minister Scott Morrison said on Tuesday, as Victoria logged the highest number of daily COVID-19 infections of any state in the country since the pandemic began.

As Merck & Co. races ahead with an experimental pill that could play a pivotal role in the fight against Covid-19, efforts are intensifying to bring the drug to developing countries that have struggled to vaccinate their populations.

Merck & Co. is discontinuing development of its two experimental Covid-19 vaccines after early trial data showed they failed to generate immune responses comparable to a natural infection or existing vaccines.

Delhi is moving towards herd immunity from coronavirus, with 50 to 60 per cent of people in one district having developed antibodies to the virus, the latest round of sero-survey has found, sources said. Herd immunity is what the authorities are trying to achieve with the vaccination programme, in which a critical mass of immune people can stop the...

Generic drug manufacturers will make a more affordable version of Merck's anti-Covid pill for 105 of the world's poorer nations, a UN-backed organisation said on Thursday.

The centre cleared two more vaccines today and one anti-viral drug to boost the fight against the COVID-19 pandemic. The two latest vaccines cleared by India are Corbevax and Covovax. The anti-viral drug Molnupiravir can be used during emergency.

A World Health Organization-led programme to ensure poorer countries get fair access to COVID-19 vaccines, tests and treatments aim to secure antiviral drugs for patients with mild symptoms for as little as $10 per course.

India's Everest Organics Ltd said on Tuesday it had started making the active pharmaceutical ingredient (API) for a generic version of Merck & Co's experimental antiviral drug molnupiravir to treat mild to moderate COVID-19.

Australia will buy 300,000 courses of Merck & Co's experimental antiviral pill, Prime Minister Scott Morrison said on Tuesday, as Victoria logged the highest number of daily COVID-19 infections of any state in the country since the pandemic began.

As Merck & Co. races ahead with an experimental pill that could play a pivotal role in the fight against Covid-19, efforts are intensifying to bring the drug to developing countries that have struggled to vaccinate their populations.

Merck & Co. is discontinuing development of its two experimental Covid-19 vaccines after early trial data showed they failed to generate immune responses comparable to a natural infection or existing vaccines.

Delhi is moving towards herd immunity from coronavirus, with 50 to 60 per cent of people in one district having developed antibodies to the virus, the latest round of sero-survey has found, sources said. Herd immunity is what the authorities are trying to achieve with the vaccination programme, in which a critical mass of immune people can stop the...